Live stream preview

Next video will start in 30 seconds

Cyclo Therapeutics (CTDH)

Close Open

Ethema Health: New Paradigm in Mental Health Treatment

Investing - Small-Cap Market Intelligence • 4m 40s

Up Next in Investing - Small-Cap Market Intelligence

  • Cyclo Therapeutics (CTDH)

    Cyclo Therapeutics (CTDH) is a clinical-stage biotechnology company that develops cyclodextrin-based products for the treatment of disease. The Company’s Trappsol® Cyclo™, an orphan drug designated product in the United States and Europe, is used to treat Niemann-Pick Disease Type C (NPC), a rare...

  • Developing Innovative Treatments for ...

    Cyclo Therapeutics (CTDH) is a clinical-stage biotechnology company that develops cyclodextrin-based products for the treatment of disease. The Company’s Trappsol® Cyclo™, an orphan drug designated product in the United States and Europe, is used to treat Niemann-Pick Disease Type C (NPC), a rare...

  • Interview with iSIGN CEO Philip Sassower

    iSIGN (OTC: ISGN) is a leading provider of digital transaction management (DTM) software enabling fully digital (paperless) business processes. iSIGN’s solutions encompass a wide array of functionality and services, including electronic signatures, simple-to-complex workflow management and variou...